Back

Mavacamten toxicity, hepatic dysfunction, and rifampicin: cause or coincidence?

European Heart Journal - Case Reports

2 June 2026
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
The evolution of the obstructive HCM therapeutic landscape: emerging evidence about cardiac myosin inhibitors
31 August 2025
thumbnail
Congress Session
Cardio-oncology: when therapy leads to failure
17 May 2025
thumbnail
Webinar
Current role of cardiovascular pharmacotherapy for arrhythmia management
9 December 2021
thumbnail
Congress Presentation
The effect of mavacamten on electrical parameters in cardiac implantable electronic devices
13 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources